PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer	SCLC	Active, not recruiting	Phase 3	2026-05-22		NCT06616532

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Biotheus Inc.	10

45 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Jining Medical University	Jining	China	12
Affiliated Hospital of Nantong University	Nantong	China	13
Anhui province hospital	Hefei	China	3
Binzhou Medical university hospital	Binzhou	China	5
First People's Hospital of Chenzhou	Chenzhou	China	2
Fujian Cancer Hospital	Fuzhou	China	37
Guangxi Medical University Cancer Hospital	Nanning	China	17
Harbin Medical University Cancer Hospital	Harbin	China	35
Hunan Cancer Hospital	Changsha	China	47
Jiangsu Province Hospital	Nanjing	China	39
Jiangxi Cancer Hospital	Nanchang	China	18
Jilin Cancer Hospital	Changchun	China	15
Jingzhou First People's Hospital	Jingzhou	China	1
Liuzhou People's Hospital	Liuzhou	China	6
Meizhou People's Hospital	Meizhou	China	6
Mianyang Central Hospital	Mianyang	China	5
Nanchong Central Hospital	Nanchong	China	2
Nanjing Drum-Tower Hospital	Nanjing	China	1
Nanyang Central Hospital	Nanyang	China	9
Qujing NO.1 Hospital	Qujing	China	1
Shandong Cancer Institute	Jinan	China	1
Sichuan Cancer Hospital	Chengdu	China	21
Taizhou Enze Medical Center (group)	Taizhou	China	1
The Affiliated Hospital Of Guilin Medical University	Guilin	China	1
The First Affiliated Hospital of Army Medical University	Chongqing	China	5

Clinical trials